Professor Preethi Kesavan, Director of Studies and Head, School of Advanced Technology and Digital Media at the London School of Business and Finance Singapore, analyses the Singaporean perspective on science and technology in advancing global healthcare.
Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.
Brian Murphy, CSO of UK digital health firm Cumulus Neuroscience, explores how AI tools could transform drug development in the difficult area of cognitive disorders.
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses a possible new treatment for endometriosis - the condition that impacts atleast 1.5 million women in the UK.
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, sheds light on food allergies and considers if this is an epidemic
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
Dr Dan Williams, SynaptixBio CEO, discusses the search to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystrophy
A new study focuses on HIV data in sub-Saharan Africa, analysing the number of people living with HIV in 47 countries, the population distribution, and the locations of healthcare facilities.
A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.
According to data collected during the first and second wave in the UK, women living in domestic abuse conditions were more likely to catch COVID - during globally observed "increased rates of violence".
